NCT02716012 2025-03-10
OUTREACH
Mina Alpha Limited
Phase 1 Unknown
Clinical Trials
4,925 trialsNCT06763250 2025-01-08
In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.
Changzhou No.2 People's Hospital
Unknown
NCT06216743 2024-12-31
PRE-MISTIC
Radboud University Medical Center
Phase NA Unknown
NCT05980403 2024-11-14
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
Renmin Hospital of Wuhan University
Unknown
NCT06344923 2024-10-16
Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy
Qilu Hospital of Shandong University
Phase NA Unknown
NCT03310632 2024-09-25
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Golden Biotechnology Corporation
Phase 1/2 Unknown
NCT05625737 2024-09-19
Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT06210724 2024-09-19
FIT in Diverticulitis
Royal Surrey County Hospital NHS Foundation Trust
Unknown
NCT05830097 2024-08-26
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Phase 1/2 Unknown
NCT05645679 2024-08-12
HYBRID
Istituto Clinico Humanitas
Unknown
NCT05996276 2024-08-09
SATIATION
University Hospital, Brest
Unknown
NCT06339346 2024-08-09
PROMOT1
University Hospital, Brest
Unknown
NCT06544083 2024-08-09
Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT06256055 2024-07-24
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Phase 1 Unknown
NCT05183243 2024-07-16
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
Phase 1 Unknown
NCT06495463 2024-07-10
Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan
Chang Gung Memorial Hospital
Phase NA Unknown
NCT06487715 2024-07-05
Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT05240625 2024-06-20
Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy.
National Taiwan University Hospital
Phase NA Unknown
NCT05832892 2024-06-14
Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 1/2 Unknown
NCT06094777 2024-06-13
A Study of HY-0102 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT06270706 2024-06-12
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Phase 1 Unknown
NCT06435741 2024-05-30
Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT06432205 2024-05-29
The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer
Peking University
Unknown
NCT05605197 2024-05-28
U87 CART in Treatment of Advanced Solid Tumor
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1 Unknown
NCT01516710 2024-05-10
Oslo-CoMet
Oslo University Hospital
Phase NA Unknown
NCT04159974 2024-05-09
RICE
University of Cologne
Phase 2 Unknown
NCT06405685 2024-05-08
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT06395337 2024-05-02
MIRCA & MIPAC
Radboud University Medical Center
Phase 1/2 Unknown
NCT06217250 2024-04-18
COWL
Istituto Clinico Humanitas
Phase NA Unknown
NCT06028516 2024-04-17
MRD Application in Colorectal Cancer Patients
Shandong First Medical University
Unknown
NCT06363123 2024-04-15
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Unknown
NCT06061445 2024-04-12
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
Phase NA Unknown
NCT05519605 2024-04-11
BESTDRAIN
Radboud University Medical Center
Unknown
NCT06353581 2024-04-09
Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
Yonsei University
Phase 2 Unknown
NCT06355700 2024-04-09
HELIO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT06346366 2024-04-04
PANORAMA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3 Unknown
NCT06347198 2024-04-04
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
NCT06348381 2024-04-04
Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation
Shanghai Chest Hospital
Unknown
NCT05106244 2024-04-03
RRTGS
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT06345300 2024-04-03
NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04674956 2024-04-02
A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
RenJi Hospital
Phase 3 Unknown
NCT06341322 2024-04-02
Using Behavioural and Cultural Insights to Increase Colorectal Cancer Home-testing in Croatia
World Health Organization
Phase NA Unknown
NCT06342323 2024-04-02
ONFM-SBRT
Peking University Third Hospital
Unknown
NCT05311618 2024-04-01
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Phase 1 Unknown
NCT05626985 2024-04-01
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
Singlera Genomics Inc.
Unknown
NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
NCT05526846 2024-03-28
Introducing a Plant-Based Diet for Patients With Colorectal Diseases
Stanford University
Phase NA Unknown
NCT06334458 2024-03-28
IMAGene
European Institute of Oncology
Phase NA Unknown
NCT06335147 2024-03-28
PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Henan Cancer Hospital
Phase NA Unknown
NCT05048524 2024-03-27
Peri-operative SLOG for Localized Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown